Petah Tikva, Israel

E Itzhak Lerner


Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 574(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: E Itzhak Lerner: Innovator in Gastrointestinal Drug Delivery Systems

Introduction

E Itzhak Lerner is a notable inventor based in Petah Tikva, Israel. He has made significant contributions to the field of drug delivery systems, particularly focusing on gastrointestinal applications. With a total of 5 patents to his name, Lerner's work has the potential to enhance the efficacy of drug administration.

Latest Patents

Lerner's latest patents include a "Delayed Total Release Two Pulse Gastrointestinal Drug Delivery System." This innovative system comprises a desired agent combined with a swellable core material, surrounded by an inner coat of water-insoluble material. The design allows for controlled release of the drug at specific sites within the gastrointestinal tract. Another significant patent is the "Immediate Release Gastrointestinal Drug Delivery System," which also utilizes a swellable core and water-insoluble coating to ensure immediate drug release upon entering the gastrointestinal tract. Both inventions aim to improve the treatment of diseases by enabling location- and time-dependent drug release.

Career Highlights

Throughout his career, Lerner has worked with various companies, including Perio Products Ltd. and Dexcel Pharma Technologies Ltd. His experience in these organizations has contributed to his expertise in developing advanced drug delivery systems.

Collaborations

Lerner has collaborated with notable professionals in his field, including Moshe Flashner and Adel Penhasi. These collaborations have likely enriched his research and development efforts.

Conclusion

E Itzhak Lerner's innovative work in gastrointestinal drug delivery systems showcases his commitment to improving medical treatments. His patents reflect a deep understanding of drug release mechanisms, which can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…